Precision Medicine Software Market
PUBLISHED: 2023 ID: SMRC22533
SHARE
SHARE

Precision Medicine Software Market

Precision Medicine Software Market Forecasts to 2028 - Global Analysis By Delivery Mode (Web & Cloud Based, On Premise), Application (Pharmacogenomics, Oncology, Rare Diseases, Other Applications), End User (Research & Government Institutes, Healthcare Providers, Pharmaceutical & Biotechnology Companies, Other End Users), and Geography

4.8 (100 reviews)
4.8 (100 reviews)
Published: 2023 ID: SMRC22533

This report covers the impact of COVID-19 on this global market
Loading...

Years Covered

2020-2028

Estimated Year Value (2022)

US $1,937 MN

Projected Year Value (2028)

US $3,633 MN

CAGR (2022 - 2028)

11.05%

Regions Covered

North America, Europe, Asia Pacific, South America, and Middle East & Africa

Countries Covered

US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa

Largest Market

Asia Pacific

Highest Growing Market

North America


According to Stratistics MRC, the Global Precision Medicine Software Market is accounted for $1,937 million in 2022 and is expected to reach $3,633 million by 2028 growing at a CAGR of 11.05% during the forecast period. The diagnosis of diseases like malignancies, infectious diseases, genetic problems, and heart diseases is made possible by precision medicine software, which comprises on-premise as well as web- and cloud-based delivery platforms. A key tool for assessing unusual ailments, identifying infectious infections, and viewing foetal aneuploidy, this programme may additionally be utilized to tailor patients' therapy.

According to National Cancer Institute, approximately 1,806,590 new cases were analyzed with cancer which led to 606,520 deaths in 2020. Moreover, the American Cancer Society identified 1.9 million cancer cases in 2021, and over 608,570 deaths were cancer-related. Similarly, CDC assessed that annual new cancer cases will be 29.5 million by 2040.



Market Dynamics:

Driver:

Growing big data analysis and IT sectors

It is projected that the cost and time required to produce new precision drugs will reduce due to the expanding advancement of big data analysis as well as the IT sector. It will be simpler to prescribe patients with the right drug to improve their health as a result of the development of new, precise medications. In order to provide Precision Medicine software, multiple genetic and diagnostic tests have to be carried out, and these tests produce a sizable amount of usable data required for customised prescriptions. The ability of IT and big data analysis to handle, analyse, and store crucial data allows clinicians to employ Precision Medicine Software.

Restraint:

Rising healthcare costs and privacy concerns

The rising cost of healthcare in the region is one of the obstacles towards the marketplace of precision medicine software throughout Europe, which will restrict its use there. Concerns regarding privacy and the security of personal data are predicted to have a detrimental effect on the development of the market business in Europe.

Opportunity:

Rising prevalence of cancer and increasing funding in cancer research

The potential of precision medicine to transform cancer care is enormous. The implementation of precision medicine in oncology would be accelerated by the rising incidence of cancer and the rising financing for cancer research. The foundation for integrating precision oncology within clinical practise is high-quality patient databases. Also, competitors in the market for precision medicine software have development potential due to developing markets and AI in medicine.

Threat:

Lack of data

Medical precision Clinical data, particularly "real-world" data on a treatment effectiveness that isn't model-based or gathered through selective research, are still not enough to support software solutions. There is even greater uncertainty with pharmacogenomic tests because they don't really practice medicine; rather, they assist doctors in making better treatment decisions.

Covid-19 Impact

Since hospitals, medical clinics, and research institutions are seeing an increase in COVID-19 cases, this could be one of the unfavourable factors preventing the market for Precision Medicine Software from expanding. Because preventing the spread of the virus is a key concern, hospitals and clinics gave COVID-19 cases precedence and restricted physical contact. The pandemic is a serious problem, particularly in the health care industry where resources and manpower are scarce and medical staffs are susceptible to infection. On the plus side, the precision medicine software can collect information from patients via their complaints or electronic medical records and can offer useful data and a trustworthy source of information.

The oncology segment is expected to be the largest during the forecast period

The oncology segment is estimated to have a lucrative growth, due to the rising incidence of cancer, the move towards personalised medicine, the increase in funding for cancer research, the use of precision medicine in oncology investigation, and the increased investments made by governmental bodies in the field of precision medicine and related software.

The healthcare providers segment is expected to have the highest CAGR during the forecast period

The healthcare providers segment is anticipated to witness the fastest CAGR growth during the forecast period, due to the increase in tertiary/specialty care hospitals, the incidence of chronic diseases, the expansion of the healthcare infrastructure, and the rise in demand for high-quality healthcare, and the transition to personalized/precision medicine.

Region with highest share:

Asia Pacific is projected to hold the largest market share during the forecast period. The move from one-size-fits-all to precision medicine, increased funding for the healthcare industry, heavily supported research initiatives, and foreign players focusing on growing their footprint in Asia Pacific are all contributing factors to the expansion. Some of the major factors expected to drive the development of the precision medicines software market in Asia-Pacific include the expanding shift in medical practise from one-size-fits-all to precision medicine, rising healthcare spending, rising funds for research activities, and increasing attention from international players to increase their presence in this region.

Region with highest CAGR:

North America is projected to have the highest CAGR over the forecast period, owing to a number of factors, including growing HCIT interests in the area, the existence of executive action facilitate business development in the US, expanding digitalization and beneficial financing initiatives by the Canadian government, can be credited for the large portion of North America's overall industry that is devoted to the precision medicine programming corporate sector. This will accelerate the target market's growth during the ensuing years.



Key players in the market

Some of the key players profiled in the Precision Medicine Software Market include Fabric Genomics, Sunquest Information Systems, Inc., AstraZeneca, AdventHealth, Foundation Medicine Inc., Syapse Inc., Translational Software Inc., Gene42 Inc., International Business Machines Corporation, LifeOmic’s Precision Health, Abbott Laboratories, Tempus Labs, Inc, NantHealth, Inc and Human Longevity, Inc.

Key Developments:

In May 2021, AdventHealth launched a data-driven precision medicine initiative and extended its genomics program to structure and merge longitudinal patient data with molecular testing data, building a dataset and disease network standards to assist the health system satisfactorily forecasting the growth of disorders and responses to therapies.

In October 2020, Fabric Genomics, a global leader in clinical genomic data interpretation, introduced Fabric GEM, a novel algorithm that rapidly and efficiently determines the probable hereditary cause of rare disorders from next-generation sequencing data, permitting more rapid diagnosis and potentially better efficacious treatment.

Delivery Modes Covered:
• Web & Cloud Based
• On Premise

Applications Covered:
• Pharmacogenomics
• Oncology
• Rare Diseases
• Other Applications

End Users Covered:
• Research & Government Institutes
• Healthcare Providers
• Pharmaceutical & Biotechnology Companies
• Other End Users

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Precision Medicine Software Market, By Delivery Mode
5.1 Introduction
5.2 Web & Cloud Based
5.3 On Premise

6 Global Precision Medicine Software Market, By Application
6.1 Introduction
6.2 Pharmacogenomics
6.3 Oncology
6.4 Rare Diseases
6.5 Other Applications

7 Global Precision Medicine Software Market, By End User
7.1 Introduction
7.2 Research & Government Institutes
7.3 Healthcare Providers
7.4 Pharmaceutical & Biotechnology Companies
7.5 Other End Users

8 Global Precision Medicine Software Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa

9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 Company Profiling
10.1 Fabric Genomics
10.2 Sunquest Information Systems, Inc.
10.3 AstraZeneca
10.4 AdventHealth
10.5 Foundation Medicine Inc.
10.6 Syapse Inc.
10.7 Translational Software Inc.
10.8 Gene42 Inc.
10.9 International Business Machines Corporation
10.10 LifeOmic’s Precision Health
10.11 Abbott Laboratories
10.12 Tempus Labs, Inc
10.13 NantHealth, Inc
10.14 Human Longevity, Inc

List of Tables
1 Global Precision Medicine Software Market Outlook, By Region (2020-2028) ($MN)
2 Global Precision Medicine Software Market Outlook, By Delivery Mode (2020-2028) ($MN)
3 Global Precision Medicine Software Market Outlook, By Web & Cloud Based (2020-2028) ($MN)
4 Global Precision Medicine Software Market Outlook, By On Premise (2020-2028) ($MN)
5 Global Precision Medicine Software Market Outlook, By Application (2020-2028) ($MN)
6 Global Precision Medicine Software Market Outlook, By Pharmacogenomics (2020-2028) ($MN)
7 Global Precision Medicine Software Market Outlook, By Oncology (2020-2028) ($MN)
8 Global Precision Medicine Software Market Outlook, By Rare Diseases (2020-2028) ($MN)
9 Global Precision Medicine Software Market Outlook, By Other Applications (2020-2028) ($MN)
10 Global Precision Medicine Software Market Outlook, By End User (2020-2028) ($MN)
11 Global Precision Medicine Software Market Outlook, By Research & Government Institutes (2020-2028) ($MN)
12 Global Precision Medicine Software Market Outlook, By Healthcare Providers (2020-2028) ($MN)
13 Global Precision Medicine Software Market Outlook, By Pharmaceutical & Biotechnology Companies (2020-2028) ($MN)
14 Global Precision Medicine Software Market Outlook, By Other End Users (2020-2028) ($MN)
15 North America Precision Medicine Software Market Outlook, By Country (2020-2028) ($MN)
16 North America Precision Medicine Software Market Outlook, By Delivery Mode (2020-2028) ($MN)
17 North America Precision Medicine Software Market Outlook, By Web & Cloud Based (2020-2028) ($MN)
18 North America Precision Medicine Software Market Outlook, By On Premise (2020-2028) ($MN)
19 North America Precision Medicine Software Market Outlook, By Application (2020-2028) ($MN)
20 North America Precision Medicine Software Market Outlook, By Pharmacogenomics (2020-2028) ($MN)
21 North America Precision Medicine Software Market Outlook, By Oncology (2020-2028) ($MN)
22 North America Precision Medicine Software Market Outlook, By Rare Diseases (2020-2028) ($MN)
23 North America Precision Medicine Software Market Outlook, By Other Applications (2020-2028) ($MN)
24 North America Precision Medicine Software Market Outlook, By End User (2020-2028) ($MN)
25 North America Precision Medicine Software Market Outlook, By Research & Government Institutes (2020-2028) ($MN)
26 North America Precision Medicine Software Market Outlook, By Healthcare Providers (2020-2028) ($MN)
27 North America Precision Medicine Software Market Outlook, By Pharmaceutical & Biotechnology Companies (2020-2028) ($MN)
28 North America Precision Medicine Software Market Outlook, By Other End Users (2020-2028) ($MN)
29 Europe Precision Medicine Software Market Outlook, By Country (2020-2028) ($MN)
30 Europe Precision Medicine Software Market Outlook, By Delivery Mode (2020-2028) ($MN)
31 Europe Precision Medicine Software Market Outlook, By Web & Cloud Based (2020-2028) ($MN)
32 Europe Precision Medicine Software Market Outlook, By On Premise (2020-2028) ($MN)
33 Europe Precision Medicine Software Market Outlook, By Application (2020-2028) ($MN)
34 Europe Precision Medicine Software Market Outlook, By Pharmacogenomics (2020-2028) ($MN)
35 Europe Precision Medicine Software Market Outlook, By Oncology (2020-2028) ($MN)
36 Europe Precision Medicine Software Market Outlook, By Rare Diseases (2020-2028) ($MN)
37 Europe Precision Medicine Software Market Outlook, By Other Applications (2020-2028) ($MN)
38 Europe Precision Medicine Software Market Outlook, By End User (2020-2028) ($MN)
39 Europe Precision Medicine Software Market Outlook, By Research & Government Institutes (2020-2028) ($MN)
40 Europe Precision Medicine Software Market Outlook, By Healthcare Providers (2020-2028) ($MN)
41 Europe Precision Medicine Software Market Outlook, By Pharmaceutical & Biotechnology Companies (2020-2028) ($MN)
42 Europe Precision Medicine Software Market Outlook, By Other End Users (2020-2028) ($MN)
43 Asia Pacific Precision Medicine Software Market Outlook, By Country (2020-2028) ($MN)
44 Asia Pacific Precision Medicine Software Market Outlook, By Delivery Mode (2020-2028) ($MN)
45 Asia Pacific Precision Medicine Software Market Outlook, By Web & Cloud Based (2020-2028) ($MN)
46 Asia Pacific Precision Medicine Software Market Outlook, By On Premise (2020-2028) ($MN)
47 Asia Pacific Precision Medicine Software Market Outlook, By Application (2020-2028) ($MN)
48 Asia Pacific Precision Medicine Software Market Outlook, By Pharmacogenomics (2020-2028) ($MN)
49 Asia Pacific Precision Medicine Software Market Outlook, By Oncology (2020-2028) ($MN)
50 Asia Pacific Precision Medicine Software Market Outlook, By Rare Diseases (2020-2028) ($MN)
51 Asia Pacific Precision Medicine Software Market Outlook, By Other Applications (2020-2028) ($MN)
52 Asia Pacific Precision Medicine Software Market Outlook, By End User (2020-2028) ($MN)
53 Asia Pacific Precision Medicine Software Market Outlook, By Research & Government Institutes (2020-2028) ($MN)
54 Asia Pacific Precision Medicine Software Market Outlook, By Healthcare Providers (2020-2028) ($MN)
55 Asia Pacific Precision Medicine Software Market Outlook, By Pharmaceutical & Biotechnology Companies (2020-2028) ($MN)
56 Asia Pacific Precision Medicine Software Market Outlook, By Other End Users (2020-2028) ($MN)
57 South America Precision Medicine Software Market Outlook, By Country (2020-2028) ($MN)
58 South America Precision Medicine Software Market Outlook, By Delivery Mode (2020-2028) ($MN)
59 South America Precision Medicine Software Market Outlook, By Web & Cloud Based (2020-2028) ($MN)
60 South America Precision Medicine Software Market Outlook, By On Premise (2020-2028) ($MN)
61 South America Precision Medicine Software Market Outlook, By Application (2020-2028) ($MN)
62 South America Precision Medicine Software Market Outlook, By Pharmacogenomics (2020-2028) ($MN)
63 South America Precision Medicine Software Market Outlook, By Oncology (2020-2028) ($MN)
64 South America Precision Medicine Software Market Outlook, By Rare Diseases (2020-2028) ($MN)
65 South America Precision Medicine Software Market Outlook, By Other Applications (2020-2028) ($MN)
66 South America Precision Medicine Software Market Outlook, By End User (2020-2028) ($MN)
67 South America Precision Medicine Software Market Outlook, By Research & Government Institutes (2020-2028) ($MN)
68 South America Precision Medicine Software Market Outlook, By Healthcare Providers (2020-2028) ($MN)
69 South America Precision Medicine Software Market Outlook, By Pharmaceutical & Biotechnology Companies (2020-2028) ($MN)
70 South America Precision Medicine Software Market Outlook, By Other End Users (2020-2028) ($MN)
71 Middle East & Africa Precision Medicine Software Market Outlook, By Country (2020-2028) ($MN)
72 Middle East & Africa Precision Medicine Software Market Outlook, By Delivery Mode (2020-2028) ($MN)
73 Middle East & Africa Precision Medicine Software Market Outlook, By Web & Cloud Based (2020-2028) ($MN)
74 Middle East & Africa Precision Medicine Software Market Outlook, By On Premise (2020-2028) ($MN)
75 Middle East & Africa Precision Medicine Software Market Outlook, By Application (2020-2028) ($MN)
76 Middle East & Africa Precision Medicine Software Market Outlook, By Pharmacogenomics (2020-2028) ($MN)
77 Middle East & Africa Precision Medicine Software Market Outlook, By Oncology (2020-2028) ($MN)
78 Middle East & Africa Precision Medicine Software Market Outlook, By Rare Diseases (2020-2028) ($MN)
79 Middle East & Africa Precision Medicine Software Market Outlook, By Other Applications (2020-2028) ($MN)
80 Middle East & Africa Precision Medicine Software Market Outlook, By End User (2020-2028) ($MN)
81 Middle East & Africa Precision Medicine Software Market Outlook, By Research & Government Institutes (2020-2028) ($MN)
82 Middle East & Africa Precision Medicine Software Market Outlook, By Healthcare Providers (2020-2028) ($MN)
83 Middle East & Africa Precision Medicine Software Market Outlook, By Pharmaceutical & Biotechnology Companies (2020-2028) ($MN)
84 Middle East & Africa Precision Medicine Software Market Outlook, By Other End Users (2020-2028) ($MN)

List of Figures

RESEARCH METHODOLOGY


Research Methodology

We at Stratistics opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.

Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.

Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.

Data Mining

The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.

Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.

Data Analysis

From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:

  • Product Lifecycle Analysis
  • Competitor analysis
  • Risk analysis
  • Porters Analysis
  • PESTEL Analysis
  • SWOT Analysis

The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.


Data Validation

The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.

We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.

The data validation involves the primary research from the industry experts belonging to:

  • Leading Companies
  • Suppliers & Distributors
  • Manufacturers
  • Consumers
  • Industry/Strategic Consultants

Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.


For more details about research methodology, kindly write to us at info@strategymrc.com

Frequently Asked Questions

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

Request Customization

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials